Research Projects

The key objectives of AE's 2016 activities are as follows:

• Increasing knowledge about current national dementia policies in order to promote best practices and reduce existing inequalities in dementia care in Europe;
• Promoting collaboration and exchange on ethical issues linked to dementia; Improving the involvement of people with dementia in...

The key objectives of Alzheimer Europe's 2017 operating grant are: the inventory and comparison of care standards for care services for people with dementia and their carers and the publiciation of results in the 2017 Dementia in Europe Yearbook, the analysis of ethical issues linked to societal obligations to people with dementia and the...

As part of its 2018 operating grant, Alzheimer Europe will aim to:

• Provide a voice to people with dementia by carrying out an inventory and analysis of existing working groups of people with dementia, their membership, working methods and findings and producing a report with the findings and identified good practices;
• Make dementia a European...

This application for a four-year framework partnership agreement is fully focused on dementia, one of the areas specifically identified as a priority area in the 2017 Call for proposals for operating grants. It builds on the work carried out by Alzheimer Europe in successive operating grants as part of its current framework partnership agreement...

In 2019, AE will:Ensure that the voices of people with dementia are duly included in all operating grant activities by involving its European Working Group of People with Dementia, organise at least three meetings of the group and collaborate closely with the 2nd Joint Action on Dementia and develop recommendations on dementia-friendly and dementia...

In 2020, AE will: Ensure that the voices of people with dementia are duly included in all operating grant activities and organise four meetings of the European Working Group of People with Dementia; Develop a guide for dementia-inclusive meetings, transport and venues building on the expectations and experiences of EWGPWD members; Collect...

Alzheimer Europe defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment option and care services". To achieve its mission, Alzheimer Europe has defined the following six objectives in its Strategic Plan which covers the period of 2006-2010: Representing...

Alzheimer Europe (AE) defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment options and care services".

Alzheimer’s disease (AD) is central to the rapidly growing and crushing ageing challenge that threatens to economically undermine today’s health care system. AD prevalence will grow to over 100m cases in 2050. AD is incurable, but can be prevented. Detecting pre-symptomatic signs of AD in at-risk groups and intervening early may be the only viable...

Alzheimer's disease (AD) is one of the most serious diseases mankind is now facing as its social and economical impacts are increasing fastly. AD is very complex and the amyloid-β (Aβ) peptide as well as metallic ions (mainly copper and zinc) have been linked to its aetiology. While the deleterious impact of Cu is widely acknowledged, intervention...

Alzheimer’s disease (AD) affects over 35 million people worldwide and yet there are currently no medicines which slow down the progress of the disease. The ADAPTED project aims to boost the development of new medicines by investigating an area of AD research which has previously received little attention – the APOE gene. The APOE gene is a well...

More than 55 million people worldwide suffer from dementia. Alzheimer disease (AD) is the main cause of this fatal disorder, without any effective disease modifying therapy. Early diagnosis and lifestyle modifications can significantly reduce the costs of care and treatment. There is no conceptual plan implementing modern diagnostic methods in the...